Ben Sykes, the executive director of the UK National Stem Cell Network, has said it was "disappointing" that the California-based biotherapeutics company Geron was closing its stem-cell programme.
Geron made the announcement on 14 November, saying it would focus on cancer treatments instead.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.